
Artificial intelligence (AI) and computational methods are a powerful tool for antibody discovery and engineering. Despite historical prevalence in small molecule-related applications, AI is progressively being utilized in the discovery and advancement of therapeutic antibodies, backed by the surge in computational power and innovative algorithms, with an increasing amount of data obtained through next-generation sequencing and related drug modalities such as VHH antibodies.1
The main uses of these approaches in antibody research involve2:
Target discovery and validation
Structural and functional modeling
Development assessment and activity improvements
De novo antibody design
In combination with other tools (e.g. bioinformatics and X-ray crystallography protein structure analysis)
These computational methods can provide much more cost-efficient and rapid turnaround time compared to the laborious experimental methods that are common in antibody discovery. Escalating costs are often a significant impediment to the advancement of drug discovery.
At Biointron, we are dedicated to accelerating your antibody discovery, optimization, and production needs. Our team of experts can provide customized solutions that meet your specific research needs. Contact us to learn more about our services and how we can help accelerate your research and drug development projects.
Norman, R. A., Ambrosetti, F., Bonvin, A. M., Colwell, L. J., Kelm, S., Kumar, S., & Krawczyk, K. (2020). Computational approaches to therapeutic antibody design: Established methods and emerging trends. Briefings in Bioinformatics, 21(5), 1549-1567. https://academic.oup.com/bib/article/21/5/1549/5581643
Kim, J., McFee, M., Fang, Q., Abdin, O., & Kim, P. M. (2023). Computational and artificial intelligence-based methods for antibody development. Trends in Pharmacological Sciences, 44(3), 175–189. https://www.cell.com/trends/pharmacological-sciences/fulltext/S0165-6147(22)00279-6
Artificial intelligence has greatly improved therapeutic antibody development, n……
Antibody affinity is a core metric in immunology and biopharmaceutical science. ……
A roundup of the biggest antibody biotech and pharma deals in December 2025.
The antibody therapeutics landscape continues to evolve rapidly, with 2026 marki……
Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.



